Investing.com - Achieve Life Sciences reported on Monday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Achieve Life Sciences announced earnings per share of $-1.350 on revenue of $0.00. Analysts polled by Investing.com EPS of $-1.130 on revenue of $62.5K.
Achieve Life Sciences 's are down 30% and is trading at $2.200 , still down 74.45% from its 52 week high of $8.61 set on Wednesday, January 5, 2022.
Achieve Life Sciences follows other major Healthcare sector earnings this month
Achieve Life Sciences's report follows an earnings beat by J&J on Tuesday, October 18, 2022, who reported EPS of $2.55 on revenue of $23.79B, EPS of $2.48 on revenue of $23.36B.
Eli Lilly had beat expectations on Tuesday, November 1, 2022 with third quarter EPS of $1.98 on revenue of $6.94B, for EPS of $1.91 on revenue of $6.91B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar